CGEN · Forms 3, 4, 5
Insider trades at COMPUGEN LTD
No open-market insider buys or sells at COMPUGEN LTD in the last 90 days; 12 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for COMPUGEN LTD (CGEN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Eran Ophir | President and CEO | Options or other derivatives | Form 4 | ||||
| Anat Cohen-Dayag | Director | Options or other derivatives | Form 4 | ||||
| Pierre Ferre | Chief Operating Officer | Options or other derivatives | Form 4 | ||||
| Zurit Levine | SVP, Business Development | Award | 18,000 | Form 4 | |||
| David Silberman | Chief Financial Officer | Award | 19,500 | Form 4 | |||
| Eran Perry | Director | Award | 7,500 | Form 4 | |||
| Russo Sharon Kredo | SVP, Research & Discovery | Award | 18,000 | Form 4 | |||
| Savitzky Kinneret Livnat | Director | Award | 7,500 | Form 4 | |||
| Mathias Hukkelhoven | Director | Award | 7,500 | Form 4 | |||
| Gilead Halevy | Director | Award | 7,500 | Form 4 | |||
| Sanford S Zweifach | Director | Award | 7,500 | Form 4 | |||
| Michelle Mahler | Chief Medical Officer | Award | 13,500 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.